Buprenorphine via Telehealth—Closing the Gap for Pregnant and Postpartum Women With Opioid Use Disorder
This Viewpoint calls for further research to guide clinicians and policymakers in increasing access and effective use of telehealth prescribing of buprenorphine for pregnant and postpartum women.
Authors
- Rachel K. Landis (ORCID: https://orcid.org/0000-0002-4618-9430)
- Barbara Andraka-Christou (ORCID: https://orcid.org/0000-0001-6307-6369)
- Mishka Terplan
- Jonathan Cantor (ORCID: https://orcid.org/0000-0003-4468-833X)
Institutions
- University of Central Florida (US)
- RAND Corporation (US)
- Friends Research Institute (US)
Publication Details
- Journal
- JAMA Internal Medicine
- Published
- 2026-09-21
- DOI
- https://doi.org/10.1001/jamainternmed.2026.4106
- Primary Topic
- Prenatal Substance Exposure Effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00